Sclerostin antibody increases bone volume and enhances implant fixation in a rat model. - Wikidata - awgldk - TriplyDB

Sclerostin antibody increases bone volume and enhances implant fixation in a rat model.

Sclerostin antibody increases bone volume and enhances implant fixation in a rat model.

http://www.wikidata.org/entity/Q36241657

about

Sclerostin Antibody Therapy for the Treatment of Osteoporosis: Clinical Prospects and Challenges A review of osteocyte function and the emerging importance of sclerostin Anti-Sclerostin antibody inhibits internalization of Sclerostin and Sclerostin-mediated antagonism of Wnt/LRP6 signaling.Dental and periodontal phenotype in sclerostin knockout mice.Pharmacologic augmentation of implant fixation in osteopenic bone.The WNT system: background and its role in bone.Sclerostin Deficiency Promotes Reparative Dentinogenesis.Systemic drugs that influence titanium implant osseointegration.Use of high resolution dual-energy x-ray absorptiometry-region free analysis (DXA-RFA) to detect local periprosthetic bone remodeling events.Intramembranous bone regeneration differs among common inbred mouse strains following marrow ablation.Preclinical models for orthopedic research and bone tissue engineering.Effects of combined human parathyroid hormone (1-34) and menaquinone-4 treatment on the interface of hydroxyapatite-coated titanium implants in the femur of osteoporotic rats.The effects of combined human parathyroid hormone (1-34) and simvastatin treatment on the interface of hydroxyapatite-coated titanium rods implanted into osteopenic rats femurs.A Review of the Impact of Implant Biomaterials on Osteocytes Biomimetic delivery of signals for bone tissue engineering

P2860

Q26744599-7F9CACE6-47F5-4A10-A554-CC49BFE322A1 Q34264395-C9460C5F-9546-4BDC-9B15-2E2856C8C591 Q34701183-BFECB937-0CCA-487B-856E-D52B3F4F7632 Q37458063-936FA67B-9D0F-4D55-B169-99043DB354AF Q38167678-5474F465-DB7C-40AC-A539-9A1959816AE8 Q38407357-597060F6-2F45-4109-BBAA-1AB22BB6AFA3 Q38750461-D1A06C63-4B4D-4E0C-A87F-8A0345A5D862 Q39061427-6D832FDE-044F-4ADC-B80B-DA6E75F78742 Q41497549-95001448-654B-42C6-9170-887A27C4A161 Q46753872-EF8C3B2D-FDCB-4B21-97CD-74C5321F9A2A Q47283862-54B3CD9E-4087-48C9-8A97-D1F911FE7710 Q47559924-D6CF2F0F-FC4B-4E8E-A767-42961B943525 Q51564940-EC5E64A4-4315-4A43-A0AC-BA5B69C52213 Q57172650-BF53FEC6-3F72-43CB-870C-A6A926A5F686 Q58695509-F24532A7-CD61-4183-85B1-025A7477A77C

P2860

Sclerostin antibody increases bone volume and enhances implant fixation in a rat model.

http://www.wikidata.org/entity/Q36241657

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Sclerostin antibody increases bone volume and enhances implant fixation in a rat model.

@ast

Sclerostin antibody increases bone volume and enhances implant fixation in a rat model.

@en

type

label

Sclerostin antibody increases bone volume and enhances implant fixation in a rat model.

@ast

Sclerostin antibody increases bone volume and enhances implant fixation in a rat model.

@en

prefLabel

Sclerostin antibody increases bone volume and enhances implant fixation in a rat model.

@ast

Sclerostin antibody increases bone volume and enhances implant fixation in a rat model.

@en

P1433

Q36241657-816020CB-B052-4438-B9B0-DC9E2A2D9001

P1476

Q36241657-EF60A81B-D8C2-459D-A7FF-ADF846490E90

P2093

Q36241657-67C686E9-8CA2-4C9F-936B-D3F76222E4B2

Q36241657-6E163616-602B-4360-A380-D64A578DAACF

Q36241657-B6CDF67B-8498-4F73-97D4-3B50D04AC7E1

Q36241657-DE7FFEB0-CD98-4740-A81B-21BC55BA0048

Q36241657-F1E3A8B6-7B05-4900-8F2A-A1A4323C1BB6

Q36241657-F2362DB0-C02A-4440-8C13-525427909C3A

P2860

Q36241657-05A96DA5-3CD0-4E8C-B1AF-A4E139D056B4

Q36241657-0AA6C0E1-F8C2-4BA5-9F86-21254A3F9070

Q36241657-0EBD1738-341A-4F19-ACE6-C65677296881

Q36241657-11F69735-26CC-47AC-A915-52B7F2E782F5

Q36241657-178B3ACD-2FAF-4AD9-A64F-0AA7AC73A1DE

Q36241657-1A1A32AA-4AC8-4631-A3DA-5DA2A70443AC

Q36241657-1D54DF30-2BED-4AF1-B77E-DC03319C3149

Q36241657-2DC3CC15-1166-4B6F-993D-48D038017AC6

Q36241657-316D09D9-A4E9-4FEC-BA36-B82246ADF508

Q36241657-3232686F-2021-4CD7-8C91-6B66AB95B3E1

P304

Q36241657-8173318D-E734-4822-A60D-2A0585020AA5

P31

Q36241657-75935BA0-F873-484A-8C31-A729A3793D92

P356

Q36241657-A3B744BD-3B58-4DBF-9BF7-9E5AFFBC423F

P407

Q36241657-0E805766-4B3A-4204-B143-27B72A577D88

P433

Q36241657-4450DA4C-398F-4054-B4F5-96AA96720A38

P478

Q36241657-BE07CED8-75EA-4225-99C7-0C5F004FE2C3

P50

Q36241657-5A572D8D-6AFC-421C-8CBD-EF19DA9C2621

P577

Q36241657-38374EA1-EA94-4564-80E6-5B7BCBC7BC39

P698

Q36241657-79B89C14-ED78-40BC-9847-C501E0B40813

P932

Q36241657-BA42DAA6-8C0A-4436-A015-5FA0E4050BAC

P356

P1433

Journal of Bone and Joint Surgery

P1476

Sclerostin antibody increases bone volume and enhances implant fixation in a rat model.

@en

P2093

Amarjit S Virdi

http://www.w3.org/2001/XMLSchema#string

Dale R Sumner

http://www.w3.org/2001/XMLSchema#string

Hua Zhu Ke

http://www.w3.org/2001/XMLSchema#string

James Maletich

http://www.w3.org/2001/XMLSchema#string

Kotaro Sena

http://www.w3.org/2001/XMLSchema#string

Min Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)

Osteocyte control of bone formation via sclerostin, a novel BMP antagonist

Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist

Control of bone mass and remodeling by PTH receptor signaling in osteocytes

BMP signaling components are expressed in human fracture callus

Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling

Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation

Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody

Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis

TGF-beta, BMPS, and their signal transducing mediators, Smads, in rat fracture healing

P304

1670-1680

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2106/JBJS.K.00344

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P50

Margaret A. McNulty

P577

2012-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22992878

http://www.w3.org/2001/XMLSchema#string

P932

3444952

http://www.w3.org/2001/XMLSchema#string